# High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting

> **NCT03079115** · PHASE4 · UNKNOWN · sponsor: **Beijing Hospital** · enrollment: 130 (estimated)

## Conditions studied

- Carotid Artery Stenosis

## Interventions

- **DRUG:** High-dose Atorvastatin
- **DRUG:** Conventional-dose Atorvastatin

## Key facts

- **NCT ID:** NCT03079115
- **Lead sponsor:** Beijing Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-21
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079115, "High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03079115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*